 Cliflical evaluation of th Orsiro LESS 10 diabetic subjects requiring coronary revasculariza t ion with Drug Eluting Stefl ts DES .880 subjects will be enrolled in this registry. The sample subjects size may be increased in order to reach the subgroup sizes Small Vessel and AMI. 